Valion Bio (VBIO) EBIT Margin Growth (3y) (2024 - 2026)
Valion Bio (VBIO) EBIT Margin Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 9,003.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 30,461.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -2,649.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -11,254.00 |
| 10 | Valion Bio | 420,133.64 | -1.78 Mn | -45,000.00 | 120,449.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120,449.00 |
| Dec 31, 2025 | 64,419.00 |
| Sep 30, 2025 | -115,897.00 |
| Jun 30, 2025 | -167,725.00 |
| Mar 31, 2025 | -162,783.00 |
| Dec 31, 2024 | -23,469.00 |
| Sep 30, 2024 | -69,203.00 |
| Jun 30, 2024 | -51,063.00 |
| Mar 31, 2024 | -11,617.00 |